Table 1.
Correlation between OS and clinical indicators of STAD patients
| Variables | Events/total (n=408) | MST (days) | Crude HR (95% CI) | Log-rank P |
|---|---|---|---|---|
| Age (years) ₤ | 0.058 | |||
| ≤60 | 43/124 | 1811 | 1 | |
| >60 | 120/278 | 779 | 1.399(0.986-1.985) | |
| Gender | 0.638 | |||
| Female | 55/143 | 940 | 1 | |
| Male | 109/265 | 881 | 1.081(0.781-1.495) | |
| Tumor Stage& | <0.0001 | |||
| Stage I | 12/52 | 2197 | 1 | |
| Stage II | 35/126 | 1686 | 1.447(0.750-2.794) | |
| Stage III | 82/174 | 766 | 2.530(1.378-4.645) | |
| Stage IV | 24/39 | 396 | 4.065(2.031-8.136) | |
| Tumor Stage& | <0.0001 | |||
| Stage I+II | 47/178 | 2197 | 1 | |
| Stage III+IV | 106/213 | 641 | 2.130(1.510-3.003) |
Notes: ₤ Age information are unavailable in 6 patients; & Tumor stage information are unavailable in 17 patients. OS, overall survival; STAD, colon adenocarcinoma; MST, median survival time; HR, hazard ratio; CI, confidence interval.